From: Analysis options for high-throughput sequencing in miRNA expression profiling
miRNA | Regulation of FTC versus FA (fold change) | Citation | Methodology | Samples | ||||
---|---|---|---|---|---|---|---|---|
HTS (A) | HTS (B) | HTS (C) | DESeq | Reference | ||||
hsa-miR-192-5p | Down (0.67) | Down (0.52) | Down (0.50) | Down (0.55) | Up (1.34) | Weber et al., JCEM [28] | Selection of markers: miRNA microarray | Selection 12 FTC & 8 FA |
hsa-miR-192-3p | **- | **- | **- | **- | ||||
hsa-miR-197-5p | **- | **- | **- | **- | Up (1.82) | |||
hsa-miR-197-3p | Up (1.26) | Up (1.50) | Up (1.30) | Up (1.39) | Validation: qPCR | Validation 5 FTC & 4 FA | ||
hsa-miR-328 | Down (0.67) | Down (0.59) | Down (0.59) | Down (0.62) | Up (1.49) | |||
hsa-miR-346 | **- | **- | **- | **- | Up (1.39) | |||
hsa-miR-146b-5p | Up (2.26) | - (1.04) | - (1.06) | - (0.80) | Up (2.8) | Nikiforova et al., JCEM [27] | Selection of markers: qPCR assay (TaqMan human panel with 158 miRNAs) | Selection 9 FTC & 8 FA |
hsa-miR-146b-3p | Up (3.14) | **- | Up (1.50) | **- | ||||
hsa-miR-155-5p* | - (1.13) | Down (0.56) | Down (0.50) | Down (0.58) | Up (5.5) | |||
hsa-miR-155-3p | **- | **- | **- | **- | ||||
hsa-miR-187-5p | **- | **- | **- | **- | Up (33.4) | |||
hsa-miR-187-3p | **- | **- | **- | **- | ||||
hsa-miR-221-5p | - (0.99) | **- | - (0.84) | **- | Up (3.6) | Validation: qPCR | Validation 5 FTC & 4 FA | |
hsa-miR-221-3p | Up (2.01) | Up (3.08) | ***Up (1.78) | Up (3.77) | ||||
hsa-miR-222-5p | **- | **- | **- | **- | Up (4.5) | |||
hsa-miR-222-3p | Up (1.96) | Up (1.52) | ***Up (1.78) | Up (1.77) | ||||
hsa-miR-224-5p | Up (2.26) | **- | **- | **- | Up (6.2) | |||
hsa-miR-224-3p | **- | **- | **- | **- | ||||
hsa-miR-199b-5p* | Up (1.58) | Up (1.31) | - (1.04) | Up (1.33) | Down (0.026) | Rossing et al., J MolEndocrinol. [29] | Selection of markers: miRNA microarray | Selection and validation 12 FTC & 12 FA |
hsa-miR-199b-3p* | Up (1.35) | Up (1.90) | - (1.19) | - (1.20) | Down (0.082) | |||
hsa-miR-144-5p | Down (0.53) | Down (0.31) | Down (0.34) | Down (0.36) | Down (0.14) | Validation: leave one out cross-validation, cell lines | ||
hsa-miR-144-3p | Down (0.47) | Down (0.50) | Down (0.51) | Down (0.43) |